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Abstract
Campylobacter jejuni is the major cause of bacterial food-borne illness in the USA and Europe. An important virulence
attribute of this bacterial pathogen is its ability to enter and survive within host cells. Here we show through a quantitative
proteomic analysis that upon entry into host cells, C. jejuni undergoes a significant metabolic downshift. Furthermore, our
results indicate that intracellular C. jejuni reprograms its respiration, favoring the respiration of fumarate. These results
explain the poor ability of C. jejuni obtained from infected cells to grow under standard laboratory conditions and provide
the bases for the development of novel anti microbial strategies that would target relevant metabolic pathways.
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Introduction
Campylobacter jejuni is the leading cause of bacterial food-borne
disease in the USA and Europe and a major cause of diarrheal
disease in developing countries [1,2]. The typical route of C. jejuni
transmission is through handling and ingesting contaminated food,
milk,orwater[3].Inmanycases,poultryisacommonsourceoffood
contamination,and the gastrointestinal tractof many species of birds
often serves as the natural reservoir of C. jejuni [4]. Despite its
important impact on public health, surprisingly little is known about
its pathogenesis [5]. Biochemical analysis and comparative genomic
studies of C. jejuni have revealed unique features in its metabolic
pathways [6–8]. Unlike most enteric bacteria, C. jejuni lacks the key
glycolytic enzyme 6-phosphofructokinase as well as alternative
pathways for sugar catabolism. Consequently, C. jejuni utilizes amino
acids and organic acids as the major carbon sources. In addition, C.
jejuni possesses highly branched electron transport chains, which
allow it to respire not only oxygen but also a variety of electron
acceptors including fumarate, nitrate, nitrite, trimethylamine-N-
oxide (TMAO), and dimethyl sulfoxide (DMSO) [9–12]. Such
remarkable diversity in its respiratory pathways may contribute to its
abilitytosurviveorgrowinsubstantiallydifferentenvironments[13].
We previously reported that C. jejuni survives within cultured
intestinal mammalian cells by avoiding its delivery to lysosomes [14].
We also found that 24 hours after infection, C. jejuni recovered from
cultured intestinal mammalian cells cannot be efficiently cultured
under microaerophilic conditions unless it is pre-incubated under
oxygen-limiting conditions.Wehypothesizedthatwithinhost cells C.
jejuni may alter its physiology and change its mode of respiration
perhaps due to low level of oxygen within the C. jejuni-containing
vacuole. Such metabolic change should most likely be reflected in
alterations on the levels of different sets of metabolic enzymes.
In an effort to understand the physiological changes in
intracellular C. jejuni we surveyed its proteome at different time
after infection of cultured mammalian cells and compared it to the
proteome of bacteria grown in vitro. Our data indicate that within
cultured mammalian cells, C. jejuni undergoes a severe metabolic
downshift and an apparent change of its respiration mode. These
data provide major insight into the in vivo metabolism and
pathogenesis of this important pathogen.
Results/Discussion
Overview of the proteomic analysis of intracellular C.
jejuni
To obtain a snapshot of C. jejuni protein expression during
infection, we developed a protocol to isolate bacteria away from
mammalian host cell proteins by exploiting C. jejuni’s moderate
resistance to detergent treatment. This protocol resulted in the
presence of very low amounts (,15%) of host cell-derived proteins
in the final preparation. COS-1 cells were infected with C. jejuni
and 2 hs and 20 hs after infection, intracellular bacteria were
isolated, and proteins from bacterial lysates were pre-fractionated
by gel electrophoresis prior to LC-MS/MS analysis. We chose to
compare these two time points because while at 2 hs after infection
C. jejuni is readily culturable under microaerophilic conditions, at
20 hs after infection it is not [14]. We also reasoned that after 2 hs
of infection, the C. jejuni proteome would closely resemble that of
extracellular bacteria allowing the opportunity to examine the
potential changes that may occur during the transition from an
extracellular to an intracellular niche. More importantly, the
comparison of proteomes of bacteria isolated by similar proce-
dures minimized potential differences due to sample processing
that could occur by comparing the proteomes of bacteria grown in
culture with that of bacteria obtained from within mammalian
cells. Samples generated with the outlined protocol (see Figure 1A)
exhibited limited host-protein contamination when examined by
both Coommassie blue staining after SDS-PAGE (Figure 1B), and
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corresponded to the mammalian cell proteome). Through the
assignments of ,400,000 MS/MS spectra we were able to detect
1,428 C. jejuni proteins, which represent ,86% of the entire C.
jejuni proteome (see Dataset S1). We used spectral counting to
assess the relative protein abundance in the different samples [15].
Most proteins in the dataset were assigned from multiple spectral
counts, which combined with the numerous technical and
biological replicates, provided strong confidence to the protein
assignments. In addition we quantified a selected group of proteins
by selective reaction monitoring (SRM) (see below) [16]. Our data
showed that proteomic differences determined by spectral counts
agreed well with those measured by SRM although in some cases
(i. e. proteins present in large amounts) spectral counting slightly
underestimated the extent of proteomic differences (reported as
the fold changes) between samples (see below). Such observation is
consistent with the fact the dynamic range of spectral counting is
not as high as that of SRM [16]. To our knowledge, this represents
the most comprehensive C. jejuni proteomic dataset available.
C. jejuni remodels its proteome within cultured
mammalian cells
After applying the criteria described in Materials and Methods,
we found 225 proteins whose levels at 20 hs after infection differed
significantly from those at 2 hs after infection (Dataset S2). The
vast majority of these proteins (211) showed significantly (p,0.05)
reduced levels at 20 hs after infection. Only a few proteins showed
a very moderate increase in their levels at 20 hs post-infection
(Dataset S2). As predicted, the proteome of C. jejuni grown in vitro
closely resembled the proteome of C. jejuni isolated from within
cultured mammalian cells 2 hs after infection (Dataset S3). We
specifically examined the profile of proteins whose levels are
known to increase as a consequence of general stress responses
[17–19] and found that their levels were either unchanged or were
even slightly decreased (Table 1). Furthermore, the levels of
proteins that are thought or known to protect C. jejuni against
oxidative stress [20] were also either decreased or unaltered
(Table 1), although their levels were relatively high in all time
points. These results suggest that C. jejuni may not be subject to
environmental stress when located within cultured mammalian
cells and have important implications for the understanding of C.
jejuni intracellular stage during infection.
C. jejuni undergoes a metabolic downshift within
cultured mammalian cells
Functional grouping of the proteins whose expression changed
upon C. jejuni’s transition from the extracellular to the intracellular
environment indicated an over representation of proteins involved
Author Summary
Campylobacter jejuni is one of the most common causes of
food-borne illness in the United States and a major cause
of diarrheal diseases in developing countries. This patho-
gen can invade intestinal epithelial cells, which is very
important for its ability to cause disease. Once it gains
access to epithelial cells, C. jejuni becomes unable to grow
under standard growth conditions, although it can grow if
pre-incubated under oxygen limiting conditions. This
study compares the protein compositions of C. jejuni
grown under standard growth conditions and obtained
from within epithelial cells. This analysis indicates that,
within cells, C. jejuni undergoes a significant metabolic
downshift and reprograms its respiration, favoring the
respiration of fumarate. These results may provide the
bases for the development of novel anti microbial
strategies that would target relevant metabolic pathways.
Figure 1. A proteomics approach to profile intracellular C. jejuni.AA schematic diagram of the experimental approach used in this study. B
SDS-PAGE analysis of extracted proteins from C. jejuni samples. Proteins obtained from intracellular bacteria isolated following the protocol described
above (intracellular), from equal number of bacteria obtained after growth in Brain Heart Infusion broth (BHI grown) or from uninfected cells
subjected to the same protocol (mock), were separated by SDS-PAGE and stained with Coomassie brilliant blue.
doi:10.1371/journal.ppat.1002562.g001
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compounds across the bacterial envelope (Figure 2). To better
evaluate the potential physiological impact of the reduction of
expression of proteins involved in metabolic pathways or transport
mechanisms, we generated a graphical metabolic network
database, using the Pathway Tools v14.0 [21]. For this purpose,
we input the C. jejuni 81–176 genome sequence [22] to the
program, which can predict pathways by matching the annotated
enzymes of the input genome with its own comprehensive
pathway/reaction database Metacyc [23]. We then manually
curated this computation-derived C. jejuni pathway database based
on published literature, such as biochemical studies on metabolic
enzymes, transporters or regulators specifically in Campylobacter
species. C. jejuni has unique metabolic capabilities presumably to
adapt to different environments, so we customized the C. jejuni
database by adding new pathways/reactions that are not present
in Metacyc, or by linking related pathways to form super-pathways
to better visualize the metabolite flow. Overall this database could
account for 155 metabolic pathways, 885 associated enzymatic
reactions, 75 transporters and 49 transport reactions. In this
graphic representation, C. jejuni proteins were mapped into
individual pathways, and were differentially labeled based on
whether they were detected in our analysis or whether their
expression level was decreased or increased. Following this
template, our proteomic analysis was able to monitor 151
metabolic pathways, 382 associated enzymes, 429 enzymatic
reactions, and 41 transporters (Figure 3) (The entire database will
be made available in the BioCyc Database collection web site
[http://biocyc.org]). Evaluation of the proteins (and associated
pathways) whose expression significantly decreased 20 hs after
infection indicates that C. jejuni undergoes a significant metabolic
downshift within host cells (Dataset S2). Several proteins associated
with various anabolic pathways showed significantly reduced levels
in samples obtained 20 hs after infection (Dataset S2 and Figure 3).
This includes components of amino acid biosynthesis pathways
such as those associated with histidine, lysine, valine, leucine,
isoleucine, methionine, glycine, and alanine biosynthesis. Similar-
ly, components of other important biosynthetic pathways includ-
ing those associated with the synthesis of prostetic groups and co-
factors, fatty acids and lipids, pentose phosphate, as well as purine
and pyrimidine nucleotides were also significantly down-regulated
20 hs after infection. In addition, the levels of several proteins
associated with various catabolic pathways were significantly
reduced in C. jejuni isolated from cells 20 hs after infection. These
include pathways involved in the degradation and utilization of
amino acids (e. g. proline, L-asparatate, lysine, serine and L-
arginine), and C1 compounds. Pathways potentially involved in
nutrient acquisition were also down-regulated, including several
amino acid ABC-type transporters as well as transporters for
phosphate, potassium, tungstate and molybdate. Overall, ,50%
of all C. jejuni proteins whose levels were decreased after 20 hs of
infection were associated with metabolic pathways or transport
reactions. Consistent with an overall metabolic downshift, the
levels of several ribosomal protein subunits (e. g. 30S ribosomal
proteins S6, S19, S15, and S20, and 50S ribosomal protein L9 and
L24) were significantly decreased. This metabolic downshift is
consistent with the observation that C. jejuni does not replicate
within cultured mammalian cells but, rather, it seems to go into a
dormant, non-culturable state [14]. In addition, the observed
metabolic downshift resembles the one observed during C. jejuni’s
Table 1. Levels of C. jejuni proteins associated with oxidative stress.
Abundance
1
Gene ID Gene symbol Protein name 2 h
2 20 h
3 Fold
4 p-value
5
CJJ81176_1234 groEL chaperonin GroEL 322 308 21.06 0.351
CJJ81176_0775 dnaK molecular chaperone DnaK 130 96 21.36 ,0.001
CJJ81176_1242 htrA protease DO 101 81 21.24 0.004
CJJ81176_1233 groES co-chaperonin GroES 13 4 23.13 0.002
CJJ81176_0774 grpE co-chaperone protein GrpE 4 4 21.04 0.660
CJJ81176_0537 clpB ATP-dependent chaperone protein ClpB 32 19 21.66 0.001
CJJ81176_1243 dnaJ-1 co-chaperone protein DnaJ 4 2 21.64 0.125
CJJ81176_1288 spoT RelA/SpoT family protein ,11 n . a
6 n.a
CJJ81176_0356 ahpC anti-oxidant AhpCTSA family protein 126 110 21.15 0.017
CJJ81176_0298 ahpC anti-oxidant AhpCTSA family protein 4 3 21.31 0.277
CJJ81176_0205 sodB superoxide dismutase, Fe 28 20 21.35 0.020
CJJ81176_0800 tpx thiol peroxidase 101 118 1.16 0.022
CJJ81176_0183 trx thioredoxin 47 20 22.17 0.005
CJJ81176_0291 biotin sulfoxide reductase 25 8 23.17 ,0.001
CJJ81176_1387 katA catalase 11 15 1.59 0.023
CJJ81176_0182 trxB thioredoxin-disulfide reductase 18 4 24.06 0.002
CJJ81176_1519 bacterioferritin, putative 56 38 21.53 0.004
1Protein abundance is indicated as averaged spectral counts from 7 biological replicates.
2C. jejuni samples isolated from host cells at 2 h of infection.
3C. jejuni samples isolated from host cells at 20 h of infection.
4Fold change in protein abundance; positive or negative values indicate higher or lower levels in the 20 h samples, respectively.
5p-values were calculated using the paired Student’s t-test.
6Data not available (due to low protein signal).
doi:10.1371/journal.ppat.1002562.t001
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observed in C. jejuni stationary phase transcriptional reprogram-
ming, we did not observe increased expression of heat shock
proteins (e. g. GroEL, GroES, GrpE, ClpB) or proteins associated
with oxidative stress resistance (e. g. AhpC, SodB, and Tpx). This
suggests that the remodeling of the C. jejuni proteome that occurs
within cultured mammalian cells is not simply the result of its
transition to a different ‘‘growth phase’’ but most likely, the result
of its specific adaptation to the intracellular environment.
C. jejuni reprograms respiration within cultured cells
The observation that intracellularly localized C. jejuni becomes
culturable after incubation under very low oxygen conditions
suggests at least two possibilities to explain its non-culturability
under standard microaerophilic conditions. One possibility is that
the intracellular remodeling of its proteome renders C. jejuni
oxygen sensitive. This hypothesis would be supported by the
observation that some proteins potentially involved in conferring
protection against oxidative stress showed reduced levels at 20 hs
after infection (Table 1). However, even though slightly reduced,
the levels of these enzymes remained relatively high. Furthermore,
no significant changes in the levels of proteins thought to be most
important in oxidative stress protection (e. g. SodB and KatA) [25–
27] were observed suggesting that other factors must account for
C. jejuni’s inability to grow under microaerophilic conditions when
directly obtained from cultured cells. Consistent with this
hypothesis, examination of the proteome of intracellularly-
localized C. jejuni suggests that it undergoes reprogramming of its
respiration. Indeed, the levels of many proteins that are central to
the main respiration pathways were significantly reduced in the
20 hs sample (Table 2), an observation confirmed by SRM
experiments (Table 3). For example, key components of the
aerobic respiration pathway [7] were greatly reduced. The C. jejuni
genome only encodes two terminal oxidases, a cbb3-type
cytochrome c oxidase and a CioAB-type (cyanide-insensitive
oxidase) oxidase [6]. The expression levels of cbb3 type
cytochrome c oxidase (CcoP and CcoO) decreased markedly
20 hs after infection (Table 2 and Table 3). The CioAB-type
oxidase could be hardly detected before and after infection, which
is consistent with the hypothesis that the cbb3-type cytochrome c
oxidase plays a more important role in aerobic respiration [28].
This hypothesis is also supported by the observation that a C. jejuni
ccoN mutant was unable to colonize chickens while a cydA mutant
colonized as well as the wild type [29]. Reduced levels of the only
enzyme that directly uses O2 as electron acceptor may make it
difficult for intracellular C. jejuni to grow under microaerophilic
conditions after its extraction from within mammalian cells. Some
components of anaerobic respiration also show reduced levels in C.
jejuni samples obtained 20 hs after infection. For example, the
levels of NapA/NrfA, involved in nitrate/nitrite respiration, and
TorA/TorC, which are central components of TMAO respira-
tion, were also markedly decreased. In contrast, the levels of the
fumarate reductase FrdA between the 2 hs and 20 hs time points
remained constant and relatively high suggesting that fumarate
may be an important electron acceptor for C. jejuni during its
intracellular stage. Thus, our proteomics data suggest that 20 hs
after infection, aerobic respiration is greatly reduced, while the
anaerobic respiration pathway can still be maintained by using
fumarate as alternative electron acceptors. Furthermore, these
results may help to explain C. jejuni’s inability to grow under
standard microaerophilic conditions when plated immediately
after its release from mammalian cells 20 hs after infection.
Although the actual oxygen concentration within the C. jejuni-
containing vacuole is unknown, during the infection process, C.
jejuni are exposed to a higher oxygen tension (5% CO2 vs. 10%
CO2 when grown microaerophilically) at least until they reach the
intracellular environment. To evaluate if this (presumably brief)
change in oxygen concentration may itself result in changes in the
C. jejuni proteome, we compared the proteome of C. jejuni
incubated in the infection medium under 5% CO2 for 2 hs
(without host cells) with the proteome of in-vitro grown bacteria.
However, we found no significant differences in the C. jejuni
proteome under these two conditions (Dataset S4) indicating that
exposure to the higher oxygen conditions during infection cannot
account for the observed changes in the intracellular population of
C. jejuni 20 hs after infection, which are most likely the direct
consequences of its adaptation into the host intracellular
environment.
We have previously shown that intracellular C. jejuni at late time
points of infection (e. g. .18 hs) can be rendered culturable under
standard microaerophilic conditions if pre-incubated under
oxygen-limiting conditions (O2,0.2%, CO2 ,6.5%) [14]. There-
fore, to gain further insight into C. jejuni’s intracellular metabolic
reprogramming, we carried out a proteomic analysis of C. jejuni
Figure 2. Functional categorization of C. jejuni proteins whose expression was lower in samples obtained 20 hours after infection.
Proteins were assigned to the different functional groups based on genome annotation and additional curation based on published literature.
doi:10.1371/journal.ppat.1002562.g002
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conditions. We reasoned that by examining changes induced by
this incubation step, which render it culturable, we might be able
to gain further insight into the changes undergone by C. jejuni when
located within the cells, which render it non-culturable. Bacteria
obtained from infected cells 20 hs after infection and incubated for
48 hs under low oxygen conditions were scraped from plates and
their proteome was examined as described above (Dataset S5). We
observed significantly increased levels of enzymes involved in
known C. jejuni anaerobic respiration pathways including FrdA,
NapA, TorA, and NrfA [12] (Dataset S6). In addition, the levels of
the anaerobic C4-dicarboxylate transporters DcuA and DcuB
were also increased after incubation under low oxygen conditions.
Strikingly, we also observed that the levels of several enzymes
involved in aerobic respiration were also increased after
incubation under oxygen-limiting conditions. For example, all
three subunits of ubiquinol-cytochrome c reductase (PetA, PetB
and PetC) were markedly increased under these conditions. These
results may provide an explanation for the observation that pre-
incubation of intracellular C. jejuni under oxygen-limiting condition
renders it ready for growth under microaerophilic environment, in
which oxygen acts as the main electron acceptor [14]. Further-
more, it suggests the possibility that the low oxygen environment
encountered by C. jejuni in the gut may also prepare the bacterium
for its phase outside the host, in which oxygen levels are likely
much higher. Interestingly, the ability to prepare for a change in a
future environment has been previously observed in V. cholera,i n
which genes required for the aquatic environment are induced
within the intestinal track, where they are not needed [30].
To gain more insight into the potential respiratory reprogram-
ming of C. jejuni within mammalian cells we specifically compared
the relative abundance of key enzymes for different respiration
pathways under the different conditions examined in this study.
We specifically examined the levels of FdhA, PetC, CcoP and
CcpA, which are involved in aerobic respiration (Figure 4A), and
FrdA, NapA, NrfA, and TorA, which are central components in
the respiration of fumarate, nitrate, nitrite and TMAO/DMSO,
respectively (see Figure 4B) [11,31,32]. For quantification we used
both spectral counting (Figure 4A and 4B) as well as SRM
(Table 3), which yielded equivalent results. We found that the
levels of aerobic respiration enzymes were markedly decreased in
intracellular C. jejuni 20 hours after infection. A similar pattern was
observed in the case of NapA and TorA. Although the levels of
NrfA remained unchanged during infection, the actual protein
levels were very low suggesting that this respiration pathway may
not be central for the metabolism of C. jejuni during its intracellular
Figure 3. Cellular overview of C. jejuni metabolic pathways. Metabolic pathways are grouped into different general functional categories as
indicated. Protein transporters are located at the double peripheral lines representing the bacterial membrane structure. Within individual pathways,
symbols represent metabolites and connecting lines denote respective enzymes that catalyze the inter-conversion of those metabolites. Most
enzymes are color-coded in the following fashion: blue indicates mapped proteins in pathways present in the C. jejuni proteome, grey indicates those
not found in the annotated genome, bold green represents those proteins whose expression levels were lower at 20 h of infection relative to 2 h of
infection, and bold red corresponds to up-regulated proteins at 20 h of infection. Description of individually numbered pathways is as follows: 1.a ,
flavin biosynthesis; b, methylerythritol phosphate pathway; c, tetrapyrrole biosynthesis; d, ubiquinone-8 biosynthesis; e, di-trans, poly-cis-
undecaprenyl phosphate biosynthesis; f, pantothenate biosynthesis I; g, chlorophyllide a biosynthesis I; h, TCA cycle; i, tetrahydrofolate biosynthesis;
j, thiamine biosynthesis I; k, pyridoxal 59-phosphate biosynthesis; l, coenzyme M biosynthesis; m, 6-hydroxymethyl-dihydropterin diphosphate
biosynthesis; n, NAD biosynthesis I; o, folate transformations p. phosphate acquisition I; q, NAD phosphorylation and dephosphorylation; r, acyl carrier
protein metabolism; s, formyl THF biosynthesis I; t, thioredoxin pathway; u, NAD salvage pathway II; v, biotin biosynthesis; w, menaquinone-8
biosynthesis; x, biotin biosynthesis; y, heme biosynthesis from uroporphyrinogen-III II; z, trans, trans-farnesyl diphosphate biosynthesis; aa,
glutathionylspermidine biosynthesis; ab, NAD salvage pathway I; ac, geranyldiphosphate biosynthesis. 2. a, histidine biosynthesis; b, lysine
biosynthesis I; c, valine biosynthesis; d, isoleucine biosynthesis I; e, threonine biosynthesis from homoserine; f, homocysteine biosynthesis; g,
homoserine biosynthesis; h, ornithine biosynthesis; i, tryptophan biosynthesis; j, proline biosynthesis I; k, S-adenosyl-L-methionine cycle I; l, serine
biosynthesis; m, alanine biosynthesis; n, tyrosine biosynthesis I; o, alanine biosynthesis III; p, selenocysteine biosynthesis I; q, glutamate biosynthesis;
r, protein citrullination; s, cysteine biosynthesis I; t, L-glutamine biosynthesis II; u, glutamine biosynthesis I; 3. a, palmitate biosynthesis II; b, CMP-KDO
biosynthesis I; c, biotin-carboxyl carrier protein assembly; d, fatty acid biosynthesis initiation III; e, CDP-diacylglycerol biosynthesis I; f, fatty acid
biosynthesis initiation II; g, cyclopropane fatty acid (CFA) biosynthesis; h, CDP-diacylglycerol biosynthesis II; i, cis-vaccenate biosynthesis; j,
phospholipid biosynthesis I; k, stearate biosynthesis II; l, fatty acid elongation-saturated. 4. a, (5R)-carbapenem biosynthesis; b, hyperforin
biosynthesis; c, myo-inositol biosynthesis. 5. a, respiration (anaerobic); b, aerobic respiration-electron donor II. 6. a. homolactic fermentation; b. (S)-
acetoin biosynthesis; c. (R)-acetoin biosynthesis I d. mixed acid fermentation; e. pyruvate fermentation to acetate; f. pyruvate fermentation to lactate.
7. a, 5-aminoimidazole ribonucleotide biosynthesis I; b, uridine-59-phosphate biosynthesis c, adenosine nucleotides de novo biosynthesis; d,
guanosine nucleotides de novo biosynthesis; e, pyrimidine deoxyribonucleotides de novo biosynthesis; f, salvage pathways of pyrimidine
ribonucleotides; g, salvage pathways of guanine, xanthine, and their nucleosides; h, salvage pathways of purine and pyrimidine nucleotides; i, salvage
pathways of purine and pyrimidine nucleotides; j, salvage pathways of purine and pyrimidine nucleotides; k, salvage pathways of purine and
pyrimidine nucleotides; l, salvage pathways of purine and pyrimidine nucleotides. 8. a, autoinducer AI-2 biosynthesis I; b, PRPP biosynthesis I. 9.
ppGpp biosynthesis. 10. a, chorismate biosynthesis I; b, 3-dehydroquinate biosynthesis I. 11. IAA biosynthesis V. 12. putrescine biosynthesis II. 13.a ,
UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (generic); b, superpathway of KDO2-lipid A biosynthesis; c, peptidoglycan biosynthesis III; d, UDP-
N-acetylmuramoyl-pentapeptide biosynthesis III (meso-DAP); e, enterobacterial common antigen biosynthesis; f, O-antigen biosynthesis; g, dTDP-L-
rhamnose biosynthesis I; h, UDP-N-acetyl-D-glucosamine biosynthesis I. 14. a, purine degradation II (anaerobic); b, purine degradation III (anaerobic);
c, formaldehyde oxidation V (tetrahydrofolate pathway); d, reductive monocarboxylic acid cycle; e, formaldehyde assimilation I (serine pathway). 15.
a, aspartate-glutamate-proline degradation; b, tyrosine degradation I; c, arginine degradation IV; d, aspartate degradation II; e, proline degradation II;
f, L-serine degradation; g, lysine degradation I; h, glutamine degradation II; i, citrulline degradation; j, proline degradation I; k, phenylalanine
degradation (aerobic); l, asparagine degradation I. 16. tRNA charging pathway. 17. a, gluconeogenesis I; b, colanic acid building blocks biosynthesis;
c, colanic acid building blocks biosynthesis; d, GDP-mannose biosynthesis; e, ADP-L-glycero-beta-D-manno-heptose biosynthesis; f, CMP-KDO
biosynthesis II; g, GDP-glucose biosynthesis; h, GDP-D-rhamnose biosynthesis; i, glycogen degradation I; j, CMP-N-acetylneuraminate biosynthesis II.
18. a, protocatechuate degradation I; b, methylgallate degradation; c, protocatechuate degradation III; d, orthanilate degradation; e, cyanurate
degradation; f, anthranilate degradation I (aerobic). 19. a, galactose degradation I; b, glycogen degradation II; c, glucose and glucose-1 phosphate
degradation. 20. a, glycolate and glyoxylate degradation I; b, pyruvate fermentation to acetate VII; c, glycolate and glyoxylate degradation II; d,
acetate conversion to acetyl-CoA. 21. a, pentose phosphate pathway (non-oxidative branch); b, pentose phosphate pathway (partial). 22. a, glycolysis
I b. glycolysis II. 23. a, seed germination protein turnover; b, wound-induced proteolysis I. 24. fatty acid and lipids degradation. 25. a, sulfate
activation for sulfonation, b, nitrate reduction III; c, nitrate reduction IV. Open triangles: Amino acids; open squares: carbohydrates; open rhomboids:
proteins; vertical ovals: purines; horizontal ovals: pyrimidines; inverted triangles: cofactors; T:tRNAs; open circles: other; closed symbols indicate
phosphorylated forms. (Note: this data has been deposited in the BioCyc home page [http://biocyc.org/] where it can be seen in an interactive fashion).
doi:10.1371/journal.ppat.1002562.g003
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samples 2 and 20 hs after infection. However, in contrast to NrfA,
the levels of FrdA were high, suggesting that fumarate may be an
important electron acceptor during C. jejuni’s intracellular stage.
Consistent with this hypothesis, the levels of AspA, which is an
aspartase that can provide fumarate for respiration [33], showed a
similar pattern to the levels of FrdA (Figure 4C), which were
characterized by unchanged although high levels 20 hs after
infection. Furthermore, the levels of AspA, FrdA and MfrA,
another fumarate reductase [11], significantly increased after
incubation under low oxygen conditions (Figure 4C).
To test the potential significance of fumarate respiration during
C. jejuni intracellular survival, we constructed C. jejuni strains
carrying mutations in aspA or the fumarate reductases frdA and/or
mfrA and examined their viability 20 hs after infection. Since in the
absence of fumarate the C. jejuni aspA, frdA,o rmfrA mutants have
been shown to be defective for invasion, these mutant strains were
grown and allowed to infect cells in the presence of fumarate, which
results in wild type levels of bacterial internalization [34]. The aspA,
frdA and frdA/mfrA mutants showed a significant decrease in viability
20 hs after infection (Figure 5, bottom graph) indicating that
respiration of fumarate is central to the metabolism of intracellular
C. jejuni. Complementation of the aspA mutant restored viability to
wild-type levels. In contrast, the mfrA mutant showed intracellular
survival close to wild type. This is consistent with the extremely low
levelsof MfrA (barelydetectable byourLC-MS approach) observed
Table 2. Levels of C. jejuni proteins associated with respiration/electron transport chains.
Abundance
1
Protein complex Gene ID Gene symbol e.c.
2 2h
3 20 h
4 O2-limiting
5 Fold
6 p-value
7
NADH dehydrogenase
8 CJJ81176_1556 nuoI 75 47 21.27 0.049
CJJ81176_1558 nuoG 15 23 20 38 21.15 0.13
CJJ81176_1561 nuoD 75 45 21.18 0.536
flavodoxin CJJ81176_1384 fldA 43 52 36 20 21.36 0.07
cytochrome c oxidase, cbb3-type CJJ81176_1479 ccoP 25 25 9 19 22.71 ,0.001
CJJ81176_1481 ccoO 26 25 12 19 22.05 ,0.001
ubiquinol–cytochrome c reductase CJJ81176_1199 petC 44 44 14 32 23.08 ,0.001
CJJ81176_1200 petB 0 ,1 ,15 n . a
9 n.a
CJJ81176_1201 petA 17 15 4 10 23.62 ,0.001
fumarate reductase CJJ81176_0432 frdC 0 ,1 ,15 n . an . a
CJJ81176_0433 frdA 82 77 62 153 21.21 0.023
CJJ81176_0434 frdB 14 11 9 28 21.02 0.379
CJJ81176_0463 mfrA 21 ,1 63 n.a n.a
CJJ81176_0464 mfrB 0 ,1 ,1 37 n.a n.a
CJJ81176_0465 mfrC 0 ,1 ,1 24 n.a n.a
nitrate reductase CJJ81176_0801 napA 60 51 9 85 25.47 ,0.001
CJJ81176_0804 napB 58 31 6 22.44 ,0.001
nitrite reductase CJJ81176_1359 nrfA 35 14 6 25.37 0.011
sulfite reductase CJJ81176_0403 yedY 44 23 21.59 0.05
TMAO reductase CJJ81176_0291 torA 28 25 8 37 23.17 ,0.001
CJJ81176_0292 torC 13 11 3 9 23.17 ,0.001
cytochrome c551 peroxidase CJJ81176_0382 ccpA-2 13 12 1 8 27.32 0.001
CJJ81176_0047 ccpA-1 77 12 27.45 ,0.001
sulfite oxidoreductase CJJ81176_0031 sorA 54 33 21.14 0.538
gluconate dehydrogenase CJJ81176_0438 23 23 4 0 25.65 ,0.001
CJJ81176_0439 86 74 29 5 22.49 ,0.001
formate dehydrogenase CJJ81176_1501 fdhC 00 04 n . a n . a
CJJ81176_1502 fdhB 12 11 3 23.48 ,0.001
CJJ81176_1503 fdhA 28 28 5 46 25.15 ,0.001
1Protein abundance is indicated as averaged spectral counts.
2Extracellular C. jejuni samples obtained from in-vitro culture.
3C. jejuni samples isolated from host cells at 2 h of infection.
4C. jejuni samples isolated from host cells at 20 h of infection.
5C. jejuni samples isolated from host cells at 20 h of infection and further incubated under oxygen-limiting conditions.
6Fold change in protein abundance; positive or negative values indicate higher or lower levels in the 20 h vs 2 h samples, respectively.
7p-values were calculated using the paired Student’s t-test.
8Other proteins encoded in the same operon (nuoNMLKJHCBA) are not listed because they were not detected or detected at very low levels. This is also the case for
other proteins relevant to respiration including CcoQN, CioAB/CydAB, NapGHLD, NrfH, YedZ, DmsABCD (dimethyl sulfoxide reductase), and SorB.
9Data not available (due to low protein signal).
doi:10.1371/journal.ppat.1002562.t002
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data are also consistent with previous observations indicatingthat C.
jejuni aspA or frdA mutant strains are impaired in chicken
colonization while the mfrA mutant is not [30][28]. To further
corroborate the hypothesis that fumarate respiration plays an
important role inC. jejuniintracellularsurvival, weexamined C. jejuni
strains carrying mutations in napG, torA, cydA,a n dfdhB for their
ability to survive within cultured mammalian cells. These genes are
involved in aerobic and anaerobic respiration pathways [29] [32].
In contrast to mutants with impaired fumarate respiration, these
mutant strains showed intracellular viability indistinguishable from
that of the wild-type (Figure 5). Therefore, our proteomic and
functional data indicate that fumarate respiration plays an
important role in C. jejuni intracellular survival.
Conclusions
We have shown here through a detailed proteomic study that
C. jejuni undergoes a significant metabolic reprogramming upon
internalization within mammalian cells. A salient feature of this
metabolic reprogramming is a significant metabolic downshift.
This metabolic downshift is qualitatively different from the one
associated with C. jejuni’s transition to stationary phase and
therefore represents a unique metabolic state presumably
associated with its adaptation to the intracellular environment.
It is also consistent with the observation that although C. jejuni
survives within mammalian cells, it does not replicate [14]. It is
therefore possible that the intracellular environment, presumably
shielded from many innate immune defense mechanisms, may
serve as a reservoir for this pathogen but not necessarily as a
replication site. The proteomic profile indicates that although
non-replicating, C. jejuni is certainly not subject to environmental
stress in this intracellular environment since none of the proteins
usually associated with responses to different environmental stress
showed increased levels. Another salient feature of the intracel-
lular metabolic reprogramming is a change in respiration mode,
which may be responsible for its decreased culturability under
Table 3. SRM measurements of a subset of C. jejuni metabolic enzymes.
Peak intensity
2 Spectral counts
4
Protein Peptide Transitions
1 2 h 20 h Fold
3 2 h 20 h Fold
5
CcoP TANENLVAK 480.4 787.5 1.25E7 5.15E6 22.4 22 10.7 22.1
480.4 471.5 5.70E5 2.90E5 22.0
480.4 394.4 2.40E5 9.40E4 22.6
NrfA KISEELK 424.2 605.6 2.30E5 4.30E4 25.3 1.7 0.7 22.4
424.2 242.3 3.20E4 6.00E3 25.3
424.2 129.1 3.90E4 7.00E3 25.6
AspA VADIALER 444.0 716.5 9.10E6 3.40E6 22.7 28 18 21.6
444.0 488.3 6.40E6 2.40E6 22.7
444.0 417.3 3.00E6 1.10E6 22.7
CcpA-2 NSGLVALPK 449.9 441.0 8.90E5 N.D.
6 N.D.
7 8.3 2 24.2
449.9 697.5 3.60E5 N.D. N.D.
449.9 527.3 2.80E5 N.D. N.D.
PetC VGLTEAAQAK 494.5 485.5 5.00E6 3.00E5 216.7 32.3 13.3 22.4
494.5 718.5 3.90E6 2.50E5 215.6
494.5 617.4 2.40E6 1.50E5 216.0
FdhA FGGGVNILR 467.1 515.3 2.20E5 4.90E4 24.5 13.3 4.3 23.1
467.1 728.5 1.60E5 3.90E4 24.1
467.1 418.3 1.00E5 2.30E4 24.3
FrdA SLVDKEGK 438.8 675.4 3.50E5 4.60E5 1.3 41 42.3 1.0
438.8 576.3 1.40E5 1.90E5 1.4
438.8 338.4 9.60E4 1.30E5 1.4
NapA LPADMVVANPK 586.1 529.3 1.90E5 5.00E4 23.8 38.3 7.3 25.2
586.1 960.6 3.70E4 8.50E3 24.4
586.1 889.6 1.80E4 4.80E3 23.8
TorA IAWTSNEQR 552.9 460.9 4.60E5 7.10E4 26.5 19.3 11.3 21.7
552.9 543.9 3.00E5 6.30E4 24.8
552.9 734.4 1.90E5 3.40E4 25.6
1For each peptide, three SRM transitions were measured.
2Intensity values were represented by integrated peak area obtained from extracted ion chromatograms.
3Fold change of fragment ion intensities between the 2 h and 20 h samples; negative values denote decreased levels in the 20 h samples.
4Spectral counts obtained for the same biological replicate.
5Fold change of peptide spectral counts between the 2 h and 20 h samples; negative values denote decreased levels in the 20 h samples.
6Peak not detected due to low peptide ion signals.
7Fold change not determined. In this case, a large negative fold value would be expected.
doi:10.1371/journal.ppat.1002562.t003
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acceptor. Indeed, our data suggest that C. jejuni may favor
fumarate respiration inside mammalian cells. Consistent with our
data, C. jeuni aspA and frdA mutants, which are defective for
fumarate respiration, were shown to be significantly impaired for
chicken colonization [30][28], while mutations in genes essential
for other respiration pathways were not [Olson, Appl Environ
Microbiol. 2008 Mar;74(5):1367–75.]. Therefore, this study
highlights the importance of metabolic reprogramming in the
biology of C. jejuni and may help the development of novel anti
microbial strategies that would target relevant metabolic
pathways.
Materials and Methods
Bacterial strains, cell lines, and culture conditions
The C. jejuni 81–176 wild-type strain, its aspA mutant, and the
complemented aspA mutant derivative have been previously
described [34,35]. All other mutant strains were constructed as
previously described [22]. Bacteria were routinely grown on blood
agar plates (tryptic soy broth agar supplemented with 5% sheep
blood) or in brain heart infusion (BHI) broth at 37uC under 10%
CO2 (microaerophilic) or low oxygen conditions (GasPak Plus,
BD-Diagnostic Systems, New Jersey). All C. jejuni strains were
stored at 280uC in BHI broth containing 30% glycerol. COS-1
(African green monkey kidney fibroblast-like cell line) cells were
obtained from the American Type Culture Collection (Manassas,
VA) and grown in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 10% bovine calf serum (BCS). All cell lines
were grown under an atmosphere of 5% CO2.
C. jejuni infection of mammalian cells and isolation of
intracellular bacteria
In order to obtain sufficient amounts of bacterial proteins for
mass spectrometric analysis (see strategy described below), we
determined that ,5610
7 to 10
8 bacteria (equivalent to ,50–
100 mg of protein yield) would be needed for proteomic analysis.
To obtain this number of bacteria C. jejuni infections were carried
out in 15-cm plates as previously described [34] with a
multiplicity of infection of 1000. Infection was allowed to proceed
for 2 hs in HBSS medium. Subsequently, cell monolayers were
washed extensively with pre-warmed HBSS and incubated in
gentamicin-containing (100 mg/mL) DMEM media for another
2 hs to kill extracellular bacteria. After gentamicin treatment,
cells were washed and lysed to release intracellular bacteria.
Alternatively, the culture media was replaced with fresh DMEM
containing lower concentration of gentamicin (10 mg/mL) and
cells were further incubated for 16 hs before releasing intracel-
lular bacteria.
A two-step differential centrifugation strategy was developed to
separate intracellular bacteria from host cell debris. COS-1 cells
were lysed in a buffer containing 0.5% Triton X-100, 20 mM
Tris-HCl (pH 7.6) and 150 mM NaCl. The sample was first
pelleted at 3006g for 5 min to remove host cell nuclei, and then
the post-nuclear supernatant was centrifuged again at 30006g for
20 min. These conditions resulted in the recovery of most of the
bacteria in the second pellet as shown by CFU assays. The
resulting bacterial pellets were washed extensively with RIPA
buffer to minimize host-protein contamination.
A general proteomic strategy for profiling C. jejuni
proteins
We carried out proteomic analysis of proteins extracted from
different C. jejuni samples by LC-MS/MS. The experimental
design is depicted in Figure 1. Briefly, intracellular C. jejuni were
harvested from mammalian cells at 2 hs and 20 hs of infection by
differential centrifugation as described above. Bacterial cell lysates
were separated by 10% SDS-PAGE to pre-fractionate the
bacterial proteins. Electrophoresis was stopped when the dye
Figure 4. Protein abundance of respiration/electron transport
chain components of C. jejuni in four distinct environments.
Protein abundance (expressed as spectral counts) in C. jejuni samples
obtained after growth in BHI, after 2 and 20 hs after infection, and after
exposure to oxygen limiting conditions subsequently to their recovery
20 hs after infection (indicated as O2-limiting). A Protein abundance of
representative enzymes involved in aerobic respirations. B Protein
abundance of representative enzymes involved in anaerobic respira-
tions. C Protein abundance of enzymes relevant to fumarate respiration.
Values represent the mean 6 standard error of the mean of three
determinations.
doi:10.1371/journal.ppat.1002562.g004
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was divided equally into three slices, each slice was subjected to in-
gel protein digestion (see below), and extracted peptide samples
were analyzed by LC-MS/MS for protein identification. Spectral
counts associated with protein assignments were utilized to
quantitatively assess their relative abundance in each sample.
Triplicate LC-MS/MS runs were conducted for each sample,
thereby allowing the assessment of the technical reproducibility of
the measurements. Statistical analysis was performed on data
obtained from 7 biological replicates. Each replicate was
comprised of two samples corresponding to two bacterial
populations (from 2 hs and 20 hs of infection). Since each
bacterial sample was divided into three gel fractions and each
fraction was run in triplicate, in total 126 LC-MS/MS
experiments were carried out to obtain the entire data set. Protein
and peptide assignments from different gel fractions were pooled
within the same bacterial sample. All mass spectrometric data have
been deposited at the public data base PRIDE hosted by EMBL-
EBI (http://www.ebi.ac.uk/pride/)
In-gel digestion of protein samples
Gel slices were excised into small (,161 mm) cubes and
transferred into sample tubes. Protein disulfide bonds were
reduced with 10 mM DTT in 100 mM NH4HCO3 at 56uC for
30 min and subsequently alkylated with 55 mM iodoacetamide
(IAM) in 100 mM NH4HCO3 at room temperature for 20 min (in
complete darkness). Upon alkylation, the gel samples were
destained with 50% acetonitrile (ACN) in 50 mM NH4HCO3
and dehydrated by addition of neat ACN. After removal of the
destaining buffer and ACN, the samples were subjected to in-gel
digestion. The digestion buffer contained 10 ng/mL trypsin in
50 mM NH4HCO3 and the enzymatic reaction was allowed to
Figure 5. Intracellular survival of C. jejuni mutant strains defective in specific respiration pathways. Cultured mammalian cells were
infected with the wild type C. jejuni 81–176 strain (WT) and the indicated mutant derivatives at a MOI of 100 for 2 hs, followed by 2 and 18 hs
incubation in the presence of gentamicin. For each strain, levels of intracellular bacteria at 20 hs after infection are shown relative to the levels
obtained at 2 hs after infection. The value of the ratio in wild type was set at 100%. The error bars represent the standard deviation of three
independent determinations. The survival values at 20 hs of the aspA, frdA,o rfrdA mfrA double mutant strains were statistically significantly different
(P,0.05, Student t test) from those of wild type.
doi:10.1371/journal.ppat.1002562.g005
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extracted from the gel matrix by equilibrating the samples with
50% ACN and 5% formic acid (FA). Finally the extracted peptides
were vacuum dried prior to LC-MS/MS analysis.
Nanoflow LC-MS/MS analysis
Nanoflow reverse-phase LC separation was carried out on a
Proxeon EASY-nLC System (Thermo Scientific). The capillary
column (75 mm6150 mm, PICOFRIT, New Objective, Woburn,
MA) was packed in-house. Briefly, a methanol slurry containing
5 mm, 100 A ˚ Magic C18AQ silica-based particles (Microm
BioResources Inc., Auburn, CA) was forced to pass through an
empty capillary (with a frit in the end) using a pressurized device.
Tryptic peptides were dissolved in HPLC-grade water and
,200 ng of samples were loaded onto the analytical column in
a single LC-MS/MS experiment. The mobile phase was
comprised of solvent A (97% H2O, 3% ACN, and 0.1% FA))
and solvent B (100% ACN and 0.1% FA). The LC separation
was carried out with the following gradient: solvent B was started
at 7% for 3 min, and then raised to 35% in 40 min; subsequently,
solvent B was rapidly increased to 90% in 2 min and maintained
for 10 min before 100% solvent A was used for column
equilibration. Peptides eluted from the capillary column were
electrosprayed directly onto a linear ion trap mass spectrometer
(LTQ Velos, ThermoElectron, San Jose, CA) for MS/MS
analysis. A data-dependent mode was enabled for peptide
fragmentation. One full MS scan was followed by fragmentation
of the top 10 most intense ions by collision-induced dissociation
(CID). Dynamic exclusion (with a duration of 6 seconds) was
enabled to preclude repeated analyses of the same precursor ion.
Both pre-column and analytical column were washed intensively
between different samples to remove any carryover from previous
runs.
Protein identifications and quantitative analysis of their
relative abundance
Peptides and proteins were assigned by a database search
method. Specifically, MS/MS scans were processed with com-
mercial software (Bioworks Browser, ThermoElectron, San Jose,
CA) to generate DTA files. Then those files were searched with
MASCOT (Matrix Science Ltd., London, UK) against a C. jejuni
81–176 protein database. The resulting peptide and protein
assignments were filtered to achieve a peptide false discovery rate
(FDR) of ,1% and a protein FDR of ,3% using the target-decoy
method (e. g. reverse database search). Protein relative abundance
between different samples was assessed using a spectral counting
method. Spectral counts represent the total number of repeated
identification of peptides for a given protein during the entire
analysis and provides a semiquantitative measurement of protein
abundance. Raw spectral counts were normalized against constant
protein signals (between 2 h and 20 h samples). Eight highly
abundant C.jejuni proteins (GroEL, AcnB, flagellin, pyruvate
ferredoxin, RpoB, RpoC, Tpx, methyl-accepting chemotaxis
protein/CJJ81176_1205) having little change in expression level
during the course of infection were chosen to calculate the final
normalization factor. A protein fold change (or ratio) between
paired samples was calculated by dividing the average spectral
counts of triplicate measurements. Then the averaged value of
ratios for 7 biological replicates was calculated for each detected
protein. A ratio (20 h over 2 h samples) greater or smaller than 1
indicates that levels of a given protein in 20 h samples were higher
or lower, respectively, than those at 2 h after infection. Paired
Student’s t test was performed on data from 7 biological replicates.
For the purpose of our analysis, differences between the average
fold change of a given protein 2 h and 20 h after infection of .2
and a p-value,0.05 were considered significant. Among those
proteins that met our criteria, a subset of metabolic enzymes of
particular interest to this study were further examined by selected
reaction monitoring (SRM).
C. jejuni infection of cultured mammalian cells
C. jejuni infection of cultured mammalian cells was also carried
out as previously described [14] with an MOI of 100. In all cases,
the C. jejuni aspA, frdA or frdA mfrA double mutant strains were
grown in the presence of fumarate and fumarate was added during
the initial infection of cultured mammalian cells. After 2 hs of
infection, cells were washed extensively with HBSS followed by the
addition of pre-warmed DMEM containing 100 mg/mL gentami-
cin for 2 hs to kill extracellular bacteria. Cells were lysed in a
buffer containing 0.5% Triton X-100, 20 mM Tris-HCl (pH 7.6),
and 150 mM NaCl, and the number of intracellular bacteria was
assessed by CFU assays. Alternatively, infected cells were washed
extensively and incubated overnight with DMEM containing
10 mg/ml of gentamicin. Cells were then lysed as described above
and the released intracellular bacteria were plated and incubated
under low-oxygen conditions for 2 days before further incubation
under microaerophilic conditions as previously described [14].
The ability of C. jejuni to survive intracellularly was assessed as a
percentage of bacteria recovered after 20 hs incubation relative to
those recovered 2 hours after infection.
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